| 1 |
34636899 | Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia. | 2022 Feb 17 |
1 |
| 2 |
35079976 | A decrease in serum 1,25(OH)2D after elective hip replacement and during bone healing is associated with changes in serum iron and plasma FGF23. | 2022 May |
2 |
| 3 |
35338393 | Use of Teriparatide in Hyperphosphatemic Familial Tumor Calcinosis: Evaluating the Interaction Between FGF23 and PTH on the Phosphaturic Effect. | 2022 Mar 25 |
1 |
| 4 |
35482362 | Regulation of 1 and 24 hydroxylation of vitamin D metabolites in the proximal tubule. | 2022 Apr 28 |
1 |
| 5 |
32504139 | New Therapies for Hypophosphatemia-Related to FGF23 Excess. | 2021 Jan |
1 |
| 6 |
32950228 | FGF23 and Cardiovascular Risk. | 2021 Jun |
1 |
| 7 |
33308018 | Development of a quantitative systems pharmacology model of chronic kidney disease: metabolic bone disorder. | 2021 Feb 1 |
1 |
| 8 |
33616655 | Alfacalcidol vs Calcitriol in the Management of Patient With Hypoparathyroidism: A Randomized Controlled Trial. | 2021 Jun 16 |
1 |
| 9 |
33694274 | Vitamin D and skeletal muscle: A narrative review focusing on chronic kidney disease and dialysis. | 2021 Mar 10 |
1 |
| 10 |
33895867 | Vitamin D Supplementation for Patients with Chronic Kidney Disease: A Systematic Review and Meta-analyses of Trials Investigating the Response to Supplementation and an Overview of Guidelines. | 2021 Aug |
1 |
| 11 |
33912412 | Diagnostic value of fibroblast growth factor 23 for abdominal aortic calcification in Indonesian hemodialysis patients. | 2021 Apr-Jun |
2 |
| 12 |
34719948 | Fibroblast growth factor 23 leads to endolysosomal routing of the renal phosphate cotransporters NaPi-IIa and NaPi-IIc in vivo. | 2021 Dec 1 |
1 |
| 13 |
31899053 | Fibroblast growth factor 23 predicts carotid atherosclerosis in individuals without kidney disease. The CORDIOPREV study. | 2020 Apr |
1 |
| 14 |
32009088 | Serum Endocrine Fibroblast Growth Factors as Potential Biomarkers for Chronic Kidney Disease and Various Metabolic Dysfunctions in Aged Patients. | 2020 |
1 |
| 15 |
32065590 | Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidney. | 2020 Mar 2 |
2 |
| 16 |
32730929 | Effects of ferric carboxymaltose on markers of mineral and bone metabolism: A single-center prospective observational study of women with iron deficiency. | 2020 Dec |
2 |
| 17 |
32984251 | Higher Fibroblast Growth Factor 23 Levels Are Causally Associated With Lower Bone Mineral Density of Heel and Femoral Neck: Evidence From Two-Sample Mendelian Randomization Analysis. | 2020 |
2 |
| 18 |
33198660 | Association of vitamin D and FGF23 with serum ferritin in hypoparathyroid thalassemia: a case control study. | 2020 Nov 16 |
1 |
| 19 |
33233840 | New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis. | 2020 Nov 20 |
2 |
| 20 |
33374582 | Caloric Intake in Renal Patients: Repercussions on Mineral Metabolism. | 2020 Dec 23 |
1 |
| 21 |
33382545 | The Putative Role of 1,25(OH)2D3 in the Association of Milk Consumption and Parkinson's Disease. | 2020 Dec 31 |
1 |
| 22 |
33393746 | The Putative Role of 1,25(OH)2D3 in the Association of Milk Consumption and Parkinson's Disease. | 2020 Dec 31 |
1 |
| 23 |
30610965 | Calcitriol, but not FGF23, increases in CSF and serum of MS patients. | 2019 Mar 15 |
2 |
| 24 |
30711691 | X-linked hypophosphatemia: Management and treatment prospects. | 2019 Nov |
1 |
| 25 |
31199502 | Regulation of fibroblast growth factor 23 (FGF23) in health and disease. | 2019 Aug |
1 |
| 26 |
31485552 | FGF23, Hypophosphatemia, and Emerging Treatments. | 2019 Aug |
1 |
| 27 |
31599133 | FGF23 and Associated Disorders of Phosphate Wasting. | 2019 Sep |
1 |
| 28 |
31850815 | Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt. | 2019 Jan-Dec |
1 |
| 29 |
28778965 | Biology of Fibroblast Growth Factor 23: From Physiology to Pathology. | 2018 May 1 |
2 |
| 30 |
29317227 | Prolonged exposure to 1,25(OH)2D3 and high ionized calcium induces FGF-23 production in intestinal epithelium-like Caco-2 monolayer: A local negative feedback for preventing excessive calcium transport. | 2018 Feb 15 |
4 |
| 31 |
29760049 | Insulin suppresses the production of fibroblast growth factor 23 (FGF23). | 2018 May 29 |
1 |
| 32 |
30013515 | FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator? | 2018 |
2 |
| 33 |
30014155 | Phosphate wasting disorders in adults. | 2018 Nov |
1 |
| 34 |
30504710 | Phosphate Homeostasis, Inflammation and the Regulation of FGF-23. | 2018 |
3 |
| 35 |
30518682 | Randomized trial of intravenous iron-induced hypophosphatemia. | 2018 Dec 6 |
1 |
| 36 |
30532527 | Levels of serum sclerostin, FGF-23, and intact parathyroid hormone in postmenopausal women treated with calcitriol. | 2018 |
1 |
| 37 |
27820122 | Tumor-induced Osteomalacia in a 3-Year-Old With Unresectable Central Giant Cell Lesions. | 2017 Jan |
1 |
| 38 |
27838783 | The FGF23 and Klotho system beyond mineral metabolism. | 2017 Mar |
1 |
| 39 |
28064234 | Effect of Calcitriol on FGF23 Level in Healthy Adults and its Dependence on Phosphate Level. | 2017 Jan 2 |
11 |
| 40 |
28509123 | Serum calcitriol levels in a patient with X-linked hypophosphatemia complicated by autosomal dominant polycystic kidney disease. | 2017 May |
1 |
| 41 |
28860784 | Effect of additive calcium administration on FGF23 levels in patients with mild chronic kidney disease treated with calcitriol: a randomized, open-labeled clinical trial. | 2017 |
5 |
| 42 |
29179169 | [Bone remodeling through a phosphate metabolism.] | 2017 |
1 |
| 43 |
26790456 | Novel biological markers of bone: from bone metabolism to bone physiology. | 2016 Oct |
1 |
| 44 |
26939683 | Fibroblast growth factor-23 and renin-angiotensin system levels in vitamin-D-dependent rickets type I. | 2016 Jul |
1 |
| 45 |
27230837 | [The pathophysiology of secondary hyperparathyroidism]. | 2016 Jun |
2 |
| 46 |
27370409 | Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function. | 2016 Sep |
3 |
| 47 |
27679712 | FGF23 in kidney transplant: the strange case of Doctor Jekyll and Mister Hyde. | 2016 Oct |
2 |
| 48 |
27934558 | Fibroblast Growth Factor 23 in Postrenal Transplant: An Often Forgotten Hormone. | 2016 Dec |
1 |
| 49 |
25652541 | Promoting effect of 1,25(OH)2 vitamin D3 in osteogenic differentiation from induced pluripotent stem cells to osteocyte-like cells. | 2015 Feb |
1 |
| 50 |
26018436 | Fibroblast Growth Factor 23: A New Dimension to Diseases of Calcium-Phosphorus Metabolism. | 2015 Sep |
1 |